Court Highlights Failures in Ensuring Timely Re-Testing of Drug Samples, Urges Administrative Review to Prevent Future Occurrences
In a significant ruling, the Jammu & Kashmir and Ladakh High Court has quashed the prosecution against Albert David Limited, a pharmaceutical company, citing procedural lapses and statutory non-compliance by the prosecution and judicial authorities. The case involved the alleged sale of substandard drugs, with the court finding that the company's statutory right to re-test the drug samples was compromised due to administrative delays and failures.
Presiding over the matter, Justice Wasim Sadiq Nargal underscored the importance of adhering to the statutory procedures outlined in the Drugs and Cosmetics Act, 1940. The judgment highlighted that the petitioner, Albert David Limited, had exercised its right for re-testing of the drug sample by the Central Drugs Laboratory, Kolkata, within the stipulated time frame. However, the court noted that the sample was never received for re-analysis, and the statutory process remained incomplete due to administrative oversights.
The court observed that the sample's shelf life expired during the prolonged delay, thereby rendering any subsequent re-testing meaningless. This lapse not only deprived the petitioner of a crucial statutory right but also violated the requirement of a fair and speedy trial under Article 21 of the Indian Constitution.
Justice Nargal emphasized that the failure to secure a timely re-analysis of the drug sample was attributable to the prosecution machinery and the court's clerical staff. The court criticized the lack of diligence and effective action from the authorities, which resulted in an abuse of the process of law.
In response to these findings, the court has directed the Registrar General to place the judgment before the Chief Justice for administrative review. Additionally, the Drug Controller, Drugs and Food Control Organization, J&K, has been instructed to form a committee to investigate the lapses and propose measures to prevent such occurrences in the future. The committee is tasked with examining potential negligence or misconduct by the officials involved, including any interference by the petitioner company.
The decision not only highlights the procedural shortcomings in handling drug sample re-testing but also serves as a reminder of the critical role timely judicial and administrative actions play in upholding public health standards.
Bottom Line :
Drugs and Cosmetics Act, 1940 - Statutory right of re-testing under Section 25(3) and (4) - Failure to ensure timely and effective compliance with statutory procedure - Prolonged delay in prosecution and expiry of drug sample shelf life render continuation of proceedings unsustainable.
Statutory provision(s): Drugs and Cosmetics Act, 1940 Sections 18(a)(i), 25(3), 25(4); Criminal Procedure Code, 1973 Section 482; Bharatiya Nagarik Suraksha Sanhita, 2023 Section 528
Albert David Limited v. Union Territory of J&K, (J&K and Ladakh) : Law Finder Doc id # 2963338
